Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Director/PDMR Shareholding

23 Sep 2020 13:12

RNS Number : 9022Z
K3 Capital Group PLC
23 September 2020
 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries, the "Group")

Director/PDMR Dealing

 

K3 Capital Group plc, a multi-disciplinary professional services firm providing advisory services to SMEs, announces that Charlotte Stranner, Independent Non-Executive Director of the Company, has purchased 6,200 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 159.5968 pence per Ordinary Share (the "Purchase").

Following the Purchase, Charlotte Stranner has a total interest over 6,200 Ordinary Shares, representing 0.01 per cent. of the Company's issued share capital. 

 

The Company makes this announcement, including the notification below, in accordance with the requirements of the EU Market Abuse Regulation.

 

For further information please contact:

 

K3 Capital Group plc

Tel: c/o finnCap 020 7220 0500

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

 

 

 

finnCap Ltd (Nominated Adviser and Sole Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Emily Watts, Charlie Beeson (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

 

 

 

About K3 Capital

K3 Capital Group plc is a multi-disciplinary professional services firm providing advisory services to SMEs, with operations throughout the UK and overseas.

Services provided by KBS Corporate, KBS Corporate Finance, Knightsbridge and KBS Capital Markets:

· Mergers and Acquisitions (M&A) - Company sales, brokerage and corporate finance services to SME's looking to achieve full or partial exit, advising on sales to private, trade, plc, private equity or overseas acquirors. Strategic advisory and valuations, financial due diligence and debt advisory.

Services provided by RandD UK Limited:

· Research & Development tax credit advisory: advising clients on Research and Development Tax Credit (RDTC) claims.

Services provided by Quantuma Advisory Limited:

· Restructuring advisory: formal insolvency appointments, informal restructuring advisory, personal insolvency and pension restructuring and insolvency advice.

· Financial advisory: comprehensive analysis of business performance through business toolkit, independent reviews, stakeholder management and turnaround and interim support.

· Creditor Services: creditor representation and liquidations.

· Forensic accounting and expert witness: forensic investigations, intelligence and forensic accounting.

· Pensions advisory: corporate and trustee advisory, pension scheme restructuring advisory, covenant advisory and expert witness.

The Group's medium-term strategy is to build a wider group of growing and complementary professional services businesses to provide SME's with high quality advice across specialist disciplines.

 K3 Capital Group trades on the London Stock Exchange (AIM: K3C.L), having listed on 11 April 2017. Please visit  www.k3capitalgroupplc.com  for more information.

 

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Charlotte Stranner

2. 

Reason for the notification

a)

Position/status:

Independent Non-Executive Director

b)

Initial notification/Amendment:

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

K3 Capital Group plc

b)

LEI:

21380043EWYIWISOAN87

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 penny per share

GB00BF1HPD20

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 Price(s)

Volume(s)

159.5968

6,200

 

d)

Aggregated information:

·Aggregated volume:

·Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Value

159.5968

6,200

£9,895

 

e)

Date of the transaction:

22/09/2020

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDCBBDDGGX
Date   Source Headline
7th Sep 20207:00 amRNSInvestor Presentation
7th Aug 20202:36 pmRNSHolding(s) in Company
7th Aug 202011:26 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSAcquisition, Directorate Changes & Results Notice
21st Jul 20204:32 pmRNSHolding(s) in Company
21st Jul 20202:51 pmRNSHolding(s) in Company
20th Jul 20203:51 pmRNSHolding(s) in Company
20th Jul 20202:35 pmRNSHolding(s) in Company
17th Jul 202011:30 amRNSResult of General Meeting
2nd Jul 20205:40 pmRNSHolding(s) in Company
2nd Jul 20205:37 pmRNSHolding(s) in Company
1st Jul 20202:37 pmRNSHolding(s) in Company
1st Jul 202011:59 amRNSHolding(s) in Company
30th Jun 20202:00 pmRNSPosting of Circular and Notice of General Meeting
29th Jun 20202:05 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 20201:25 pmRNSResult of Fundraising
29th Jun 20207:01 amRNSPrimaryBid.com Offers
29th Jun 20207:00 amRNSProposed Fundraising to Raise up to £30.5 million
7th Apr 20204:42 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSTrading Update
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
28th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20203:00 pmRNSDirector/PDMR Shareholding
5th Feb 20202:30 pmRNSDirector/PDMR Shareholding
4th Feb 20207:00 amRNSHalf-year Report
16th Dec 20197:00 amRNSTrading Update
20th Nov 20196:05 pmRNSHolding(s) in Company
18th Oct 20191:30 pmRNSResult of AGM
17th Sep 20191:43 pmRNSFinal Dividend Timetable
17th Sep 20197:00 amRNSNotice of AGM
17th Sep 20197:00 amRNSFinal Results
21st Aug 201910:25 amRNSHolding(s) in Company
17th Jun 201912:00 pmRNSCorrection: Director/PDMR Shareholding
14th Jun 20192:40 pmRNSDirector/PDMR Shareholding
6th Jun 20192:09 pmRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSTrading Update and Notice of Results
16th May 20194:30 pmRNSHolding(s) in Company
8th Apr 201911:41 amRNSHolding(s) in Company
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSHalf-year Report
12th Dec 20187:00 amRNSLeading Advisor in Mid-Market M&A Adviser Rankings
11th Dec 20187:00 amRNSTrading Update
6th Dec 20184:52 pmRNSHolding(s) in Company
11th Oct 201811:05 amRNSSecond Price Monitoring Extn
11th Oct 201811:00 amRNSPrice Monitoring Extension
26th Sep 20185:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.